LNAI
Lunai Bioworks
LNAI
LNAI
37 hedge funds and large institutions have $3.73M invested in Lunai Bioworks in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
52% less call options, than puts
Call options by funds: $13K | Put options by funds: $27K
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
37
Holding in Top 10
–
Calls
$13K
Puts
$27K
Top Buyers
| 1 | +$35.9K | |
| 2 | +$24.3K | |
| 3 | +$20.1K | |
| 4 |
CF
Cantor Fitzgerald
New York
|
+$14.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$12K |
Top Sellers
| 1 | -$79.9K | |
| 2 | -$51.8K | |
| 3 | -$48K | |
| 4 |
Two Sigma Advisers
New York
|
-$34.1K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$28K |